FDA panel backs Pfizer RSV vaccine for older Americans
Mar 01, 2023
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86%.
FDA gives Moderna COVID-19 vaccine full approval
Jan 31, 2022
Vaccine, which has been available for the age group under emergency use authorization, will be marketed as Spikevax.
FDA approves Moderna, J&J booster shots, backs mix ‘n’ match vaccines
Oct 21, 2021
The agency’s decision is one of the last steps toward a full rollout of booster shots to eligible Americans.
FDA expert panel to weigh approval of Moderna, Johnson & Johnson booster shots
Oct 13, 2021
The panel will consider whether a third Moderna shot should contain half the original dose, as well as the best timing for a second shot of single-dose J&J vaccine.
CDC panel advises that other vaccines are preferred over J&J Shot
Dec 16, 2021
The ACIP voted unanimously on Thursday afternoon on ‘updated recommendations for use’ of the single-dose vaccine.
Racial/ethnic disparities persist in adult vaccination coverage
Jul 29, 2021
Racial and ethnic disparities in vaccine coverage persisted over the last decade among adults aged 65 years and older, according to a study published online July 29 in the American Journal of Preventive...
All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
Neutralization titers against omicron up with mRNA-1273 boost
Jan 28, 2022
After a mRNA-1273 (Moderna) boost, neutralization titers against the omicron variant were 20 times higher than than those at one month after second dose.